Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
AstraZeneca
Argus Health
Chubb
Moodys
Federal Trade Commission
Julphar
US Army
McKesson
Chinese Patent Office

Generated: February 21, 2018

DrugPatentWatch Database Preview

Sulfadiazine - Generic Drug Details

« Back to Dashboard

What are the generic sources for sulfadiazine and what is the scope of sulfadiazine freedom to operate?

Sulfadiazine
is the generic ingredient in three branded drugs marketed by Abbvie, Everylife, Impax Labs, Lannett, Lederle, Lilly, and Sandoz, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for sulfadiazine. One supplier is listed for this compound.
Pharmacology for sulfadiazine
Ingredient-typeSulfonamides
Drug ClassSulfonamide Antibacterial
Medical Subject Heading (MeSH) Categories for sulfadiazine

US Patents and Regulatory Information for sulfadiazine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett SULFADIAZINE sulfadiazine TABLET;ORAL 080084-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Impax Labs SULFADIAZINE sulfadiazine TABLET;ORAL 080081-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly SULFADIAZINE sulfadiazine TABLET;ORAL 004122-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz SULFADIAZINE sulfadiazine TABLET;ORAL 040091-001 Jul 29, 1994 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Everylife SULFADIAZINE sulfadiazine TABLET;ORAL 080088-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lederle SULFADIAZINE sulfadiazine TABLET;ORAL 004054-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly SULFONAMIDES DUPLEX sulfadiazine; sulfamerazine SUSPENSION;ORAL 006317-007 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lederle SULFADIAZINE SODIUM sulfadiazine sodium INJECTABLE;INJECTION 004054-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie SULFADIAZINE sulfadiazine TABLET;ORAL 004125-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Medtronic
Daiichi Sankyo
Baxter
Accenture
Moodys
Teva
Cipla
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot